Unknown

Dataset Information

0

Emerging therapies for hemophilia: controversies and unanswered questions.


ABSTRACT: Several new therapies for hemophilia have emerged in recent years. These strategies range from extended half-life factor replacement products and non-factor options with improved pharmacokinetic profiles to gene therapy aiming for phenotypic cure. While these products have the potential to change hemophilia care dramatically, several challenges and questions remain regarding broader applicability, long-term safety, and which option to pursue for each patient. Here, we review these emerging therapies with a focus on controversies and unanswered questions in each category.

SUBMITTER: Arruda VR 

PROVIDER: S-EPMC5931262 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature

altmetric image

Publications

Emerging therapies for hemophilia: controversies and unanswered questions.

Arruda Valder R VR   Doshi Bhavya S BS   Samelson-Jones Benjamin J BJ  

F1000Research 20180424


Several new therapies for hemophilia have emerged in recent years. These strategies range from extended half-life factor replacement products and non-factor options with improved pharmacokinetic profiles to gene therapy aiming for phenotypic cure. While these products have the potential to change hemophilia care dramatically, several challenges and questions remain regarding broader applicability, long-term safety, and which option to pursue for each patient. Here, we review these emerging thera  ...[more]

Similar Datasets

| S-EPMC5626534 | biostudies-literature
| S-EPMC5843471 | biostudies-other
| S-EPMC8965548 | biostudies-literature
| S-EPMC6774054 | biostudies-literature
| S-EPMC6027345 | biostudies-literature
| S-EPMC9605063 | biostudies-literature
| S-EPMC9816530 | biostudies-literature
| S-EPMC3788781 | biostudies-literature
| S-EPMC8258051 | biostudies-literature
| S-EPMC10861218 | biostudies-literature